Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1996-5-23
|
| pubmed:abstractText |
Endothelial cell (EC) activation is a consistent feature of discordant xenograft rejection. Treatment of xenograft recipients with complement inhibitors and xenoreactive natural antibody depletion leads to delayed xenograft rejection associated with a cellular infiltrate comprising up to 20% natural killer (NK) cells. To determine the importance of NK cells in xenograft rejection, we studied EC activation and cytotoxicity in co-cultures containing human NK cells and porcine EC. The addition of freshly isolated NK cells to porcine EC resulted in EC cell activation, characterized by the induction of mRNA and protein for the adhesion molecule E-selectin and the chemotactic cytokine interleukin (IL)-8. The induction of E-selectin and IL-8 occurred with three separate sources of NK cells: purified CD56+ve cells, the NK cell clone B22, and the Fc receptor-deficient NK cell line NK92. Transwell cultures demonstrated that direct NK-EC contact was required for the EC induction of E-selectin and IL-8. These effects could not be inhibited with human recombinant tumor necrosis factor-alpha receptor, and the transfer of supernatants or cell lysates from activated EC to secondary cultures did not result in EC activation. The addition of human IgG enhanced the level of E-selectin expression and cellular cytotoxicity, and resulted in tumor necrosis factor-alpha and interferon-gamma secretion. Thus, human NK cells can lyse or activate EC by direct cell contact and the addition of IgG enhances EC activation and NK cell cytokine secretion. These findings implicate NK cells in EC activation and cell-mediated xenograft rejection.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/E-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0041-1337
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
61
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
763-71
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:8607181-Animals,
pubmed-meshheading:8607181-Base Sequence,
pubmed-meshheading:8607181-Cell Adhesion,
pubmed-meshheading:8607181-Cell Communication,
pubmed-meshheading:8607181-Cell Line,
pubmed-meshheading:8607181-E-Selectin,
pubmed-meshheading:8607181-Endothelium, Vascular,
pubmed-meshheading:8607181-Graft Rejection,
pubmed-meshheading:8607181-Humans,
pubmed-meshheading:8607181-Immunoglobulin G,
pubmed-meshheading:8607181-Interleukin-8,
pubmed-meshheading:8607181-Killer Cells, Natural,
pubmed-meshheading:8607181-Mice,
pubmed-meshheading:8607181-Molecular Sequence Data,
pubmed-meshheading:8607181-RNA, Messenger,
pubmed-meshheading:8607181-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:8607181-Swine,
pubmed-meshheading:8607181-Transplantation, Heterologous
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
Direct activation of porcine endothelial cells by human natural killer cells.
|
| pubmed:affiliation |
Sandoz Center for Immunobiology, Harvard Medical School, Boston, Massachusetts 02215, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|